Whitehawk Therapeutics (WHWK) Prepaid Assets (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Prepaid Assets of $2.5 million for Q1 2026, up 61.4% year-over-year from $1.6 million in Q1 2025, and down 24.46% quarter-over-quarter from $3.3 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Prepaid Assets (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 16 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $2.5 million, up 61.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 61.4% YoY), and the FY2025 annual result was $3.3 million, up 16.93% from the prior year.
- Prepaid Assets declined to $2.5 million in Q1 2026 per WHWK's latest filing, from $3.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $4.4 million in Q1 2023 and troughed at $1.5 million in Q2 2025.
- A 5-year average of $3.0 million and a median of $2.9 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 1012.88% in 2022, then tumbled 54.79% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $3.7 million in 2022, then rose by 2.14% to $3.8 million in 2023, then fell by 25.88% to $2.8 million in 2024, then climbed by 16.93% to $3.3 million in 2025, then declined by 24.46% to $2.5 million in 2026.
- Business Quant data shows WHWK's Prepaid Assets at $2.5 million in Q1 2026, $3.3 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.51 Mn |
| Dec 31, 2025 | 3.32 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Sep 30, 2024 | 2.69 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Mar 31, 2022 | 2.86 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | 643,000.00 |
| Jun 30, 2021 | 578,461.00 |